rethinkPeptides Search
Menu
Study breakdown

Diabetes Reduces the Brain's Production of Natural Painkilling Opioid Peptides

Animal StudyPreliminary evidence
The takeaway

Diabetes significantly reduced POMC gene expression in both the hypothalamus and pituitary of rats, and insulin treatment restored it, linking diabetic neuropathy to opioid peptide deficiency.

Insulin restores opioids

Insulin treatment normalized POMC expression that was suppressed by diabetes, suggesting proper glucose control protects the brain's natural pain relief system

What the researchers found

STZ-induced diabetes decreased POMC mRNA by significant amounts in the hypothalamic arcuate nucleus and anterior pituitary by 2-4 weeks, with insulin treatment (3 weeks) normalizing expression levels.

Why it matters

Diabetic neuropathy causes significant pain and suffering. If diabetes suppresses the brain's natural opioid production, this provides a mechanism for diabetic pain syndromes and suggests opioid peptide supplementation could help.

How the study worked

Animal study in rats with STZ-induced diabetes. Three groups: 2-week diabetic, 4-week diabetic, and 4-week diabetic with 3 weeks insulin treatment. POMC mRNA measured by in situ hybridization in arcuate nucleus and anterior pituitary.

What this study cannot tell us

Rat diabetes model (STZ) may not perfectly replicate human type 1 or type 2 diabetes. POMC mRNA changes don't necessarily equate to proportional changes in active peptide levels. The functional pain consequences were not directly measured.

How to read the evidence

Preliminary animal evidence with clear molecular findings in a standard diabetes model, but functional pain consequences not assessed.

When this study was published

Published in 1999. The connection between diabetes, opioid peptides, and pain regulation continues to be studied.

The bigger picture

Diabetes doesn't just damage peripheral nerves — it disrupts central pain control by reducing opioid peptide production. This whole-system perspective on diabetic neuropathy could change how we approach pain management in diabetes.

Questions still open

  • Is POMC expression reduced in human diabetic patients?
  • Could opioid peptide supplementation help manage diabetic neuropathy?
  • Does the type of diabetes (1 vs 2) affect POMC expression differently?

Common questions

Does diabetes affect your natural painkillers?
Yes. This study shows diabetes reduces production of POMC, the gene that makes beta-endorphin and other natural opioid painkillers. This could contribute to the pain sensitivity and neuropathy seen in diabetes.
Does insulin help protect the opioid system?
In this study, insulin treatment restored opioid peptide gene expression to near-normal levels. This suggests that good blood sugar control with insulin may help maintain the brain's natural pain relief system.

Read the original research

STZ-induced diabetes decreases and insulin normalizes POMC mRNA in arcuate nucleus and pituitary in rats.

The American journal of physiology, 276(5), R1320-6

Citation

Kim, E M; Grace, M K; Welch, C C; Billington, C J; Levine, A S. (1999). STZ-induced diabetes decreases and insulin normalizes POMC mRNA in arcuate nucleus and pituitary in rats.. The American journal of physiology, 276(5), R1320-6. https://doi.org/10.1152/ajpregu.1999.276.5.R1320